Lincoln Pharmaceuticals Ltd reports 57.85% rise in the Standalone Net Profit at ₹ 23.74 crore in Q2 FY23
Mr . Mahendra Patel, Managing Director, Lincoln Pharmaceuticals Ltd Highlights:- · Total Income from operation in Q2 FY23 at ₹ 146.30 crore, up 12.5% from ₹ 130.00 crore in Q1 … Read More